Living donor liver transplantation for hepatitis C.
Liver cirrhosis and hepatocellular carcinoma related to chronic hepatitis C virus (HCV) infection are currently the most common indications for liver transplantation. The number of living donor liver transplantation (LDLT) procedures has increased given the shortage of donor organs from deceased donors. However, recurrence of HCV infection is universal and affects graft survival. This mini-review compared the outcomes for HCV-positive recipients after LDLT with those after deceased donor liver transplantation.
Department of Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, 791-0295, Japan. takaday@m.ehime-u.ac.jp
Yasutsugu
Y
Takada
Shinji
S
Uemoto
D000367:Age Factors; D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000601:surgery*; D005260:Female; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology* / Q000601:surgery*; D008113:Liver Neoplasms / Q000209:etiology* / Q000601:surgery*; D016031:Liver Transplantation; D019520:Living Donors; D008297:Male; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome